Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Emiliano Dalla
Affiliation
University of Udine
ORCID
Career Start Year
2002
Papers
42
H Index
16
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36855946
AUF1 Recognizes 8-Oxo-Guanosine Embedded in DNA and Stimulates APE1 Endoribonuclease Activity.
Antioxid Redox Signal
2023
37719963
Clinical Significance of Apurinic/Apyrimidinic Endodeoxyribonuclease 1 and MicroRNA Axis in Hepatocellular Carcinoma.
J Clin Transl Hepatol
2023
36855946
AUF1 Recognizes 8-Oxo-Guanosine Embedded in DNA and Stimulates APE1 Endoribonuclease Activity.
Antioxid Redox Signal
2023
37419964
Ceramide releases exosomes with a specific miRNA signature for cell differentiation.
Sci Rep
2023
37719963
Clinical Significance of Apurinic/Apyrimidinic Endodeoxyribonuclease 1 and MicroRNA Axis in Hepatocellular Carcinoma.
J Clin Transl Hepatol
2023
37419964
Ceramide releases exosomes with a specific miRNA signature for cell differentiation.
Sci Rep
2023
35203343
Reinfection of Transplanted Livers in HCV- and HCV/HIV-Infected Patients Is Characterized by a Different MicroRNA Expression Profile.
Cells
2022
36156150
A regulatory network comprising let-7 miRNA and SMUG1 is associated with good prognosis in ER+ breast tumours.
Nucleic Acids Res
2022
35884475
Identification of a Prognostic Microenvironment-Related Gene Signature in Glioblastoma Patients Treated with Carmustine Wafers.
Cancers (Basel)
2022
36012423
Combining Deep Phenotyping of Serum Proteomics and Clinical Data via Machine Learning for COVID-19 Biomarker Discovery.
Int J Mol Sci
2022
35876890
APE1 controls DICER1 expression in NSCLC through miR-33a and miR-130b.
Cell Mol Life Sci
2022
36195608
Proteotoxic stress-induced apoptosis in cancer cells: understanding the susceptibility and enhancing the potency.
Cell Death Discov
2022
35288800
Identification of a gene signature for the prediction of recurrence and progression in non-muscle-invasive bladder cancer.
Mol Biomed
2022
35203343
Reinfection of Transplanted Livers in HCV- and HCV/HIV-Infected Patients Is Characterized by a Different MicroRNA Expression Profile.
Cells
2022
35150567
Transcriptomic and genomic studies classify NKL54 as a histone deacetylase inhibitor with indirect influence on MEF2-dependent transcription.
Nucleic Acids Res
2022
36195608
Proteotoxic stress-induced apoptosis in cancer cells: understanding the susceptibility and enhancing the potency.
Cell Death Discov
2022
35884475
Identification of a Prognostic Microenvironment-Related Gene Signature in Glioblastoma Patients Treated with Carmustine Wafers.
Cancers (Basel)
2022
36012423
Combining Deep Phenotyping of Serum Proteomics and Clinical Data via Machine Learning for COVID-19 Biomarker Discovery.
Int J Mol Sci
2022
36156150
A regulatory network comprising let-7 miRNA and SMUG1 is associated with good prognosis in ER+ breast tumours.
Nucleic Acids Res
2022
35876890
APE1 controls DICER1 expression in NSCLC through miR-33a and miR-130b.
Cell Mol Life Sci
2022
35288800
Identification of a gene signature for the prediction of recurrence and progression in non-muscle-invasive bladder cancer.
Mol Biomed
2022
35150567
Transcriptomic and genomic studies classify NKL54 as a histone deacetylase inhibitor with indirect influence on MEF2-dependent transcription.
Nucleic Acids Res
2022
33159916
Heart failure impairs the mechanotransduction properties of human cardiac pericytes.
J Mol Cell Cardiol
2021
33966634
HDAC4 degradation during senescence unleashes an epigenetic program driven by AP-1/p300 at selected enhancers and super-enhancers.
Genome Biol
2021
33785653
Enhancing Proteotoxic Stress in Leiomyosarcoma Cells Triggers Mitochondrial Dysfunctions, Cell Death, and Antitumor Activity <i>in vivo</i>.
Mol Cancer Ther
2021
34154611
Integrated multi-omics analyses on patient-derived CRC organoids highlight altered molecular pathways in colorectal cancer progression involving PTEN.
J Exp Clin Cancer Res
2021
33878891
A regulative epigenetic circuit supervised by HDAC7 represses IGFBP6 and IGFBP7 expression to sustain mammary stemness.
Epigenomics
2021
33818800
miRNA expression profiles in liver grafts of HCV and HIV/HCV-infected recipients, 6 months after liver transplantation.
J Med Virol
2021
33159916
Heart failure impairs the mechanotransduction properties of human cardiac pericytes.
J Mol Cell Cardiol
2021
33878891
A regulative epigenetic circuit supervised by HDAC7 represses IGFBP6 and IGFBP7 expression to sustain mammary stemness.
Epigenomics
2021
33818800
miRNA expression profiles in liver grafts of HCV and HIV/HCV-infected recipients, 6 months after liver transplantation.
J Med Virol
2021
33785653
Enhancing Proteotoxic Stress in Leiomyosarcoma Cells Triggers Mitochondrial Dysfunctions, Cell Death, and Antitumor Activity <i>in vivo</i>.
Mol Cancer Ther
2021
33966634
HDAC4 degradation during senescence unleashes an epigenetic program driven by AP-1/p300 at selected enhancers and super-enhancers.
Genome Biol
2021
34154611
Integrated multi-omics analyses on patient-derived CRC organoids highlight altered molecular pathways in colorectal cancer progression involving PTEN.
J Exp Clin Cancer Res
2021
32244430
Cleavage of the APE1 N-Terminal Domain in Acute Myeloid Leukemia Cells Is Associated with Proteasomal Activity.
Biomolecules
2020
31913336
Architecture of The Human Ape1 Interactome Defines Novel Cancers Signatures.
Sci Rep
2020
32244430
Cleavage of the APE1 N-Terminal Domain in Acute Myeloid Leukemia Cells Is Associated with Proteasomal Activity.
Biomolecules
2020
31754707
Different class IIa HDACs repressive complexes regulate specific epigenetic responses related to cell survival in leiomyosarcoma cells.
Nucleic Acids Res
2020
31858150
New perspectives in cancer biology from a study of canonical and non-canonical functions of base excision repair proteins with a focus on early steps.
Mutagenesis
2020
34233432
Role of phase partitioning in coordinating DNA damage response: focus on the Apurinic Apyrimidinic Endonuclease 1 interactome.
Biomol Concepts
2020
33287106
The miRNA Content of Exosomes Released from the Glioma Microenvironment Can Affect Malignant Progression.
Biomedicines
2020
33066172
Heterogeneity Matters: Different Regions of Glioblastoma Are Characterized by Distinctive Tumor-Supporting Pathways.
Cancers (Basel)
2020
34233432
Role of phase partitioning in coordinating DNA damage response: focus on the Apurinic Apyrimidinic Endonuclease 1 interactome.
Biomol Concepts
2020
31754707
Different class IIa HDACs repressive complexes regulate specific epigenetic responses related to cell survival in leiomyosarcoma cells.
Nucleic Acids Res
2020
31858150
New perspectives in cancer biology from a study of canonical and non-canonical functions of base excision repair proteins with a focus on early steps.
Mutagenesis
2020
31913336
Architecture of The Human Ape1 Interactome Defines Novel Cancers Signatures.
Sci Rep
2020
33287106
The miRNA Content of Exosomes Released from the Glioma Microenvironment Can Affect Malignant Progression.
Biomedicines
2020
33066172
Heterogeneity Matters: Different Regions of Glioblastoma Are Characterized by Distinctive Tumor-Supporting Pathways.
Cancers (Basel)
2020
30531872
Immune genes are primed for robust transcription by proximal long noncoding RNAs located in nuclear compartments.
Nat Genet
2019
31601109
Role of Multimodality Imaging in a Case of Aortic Prosthetic Endocarditis: A Diagnostic and Therapeutic Challenge.
Circ Cardiovasc Imaging
2019
1 - 50 of 84
Column Actions
Search
Recommended Authors
Tuo Zhang
Weill Cornell Medical College.
Career Start Year
2013
Number of shared co-authors
0
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Career Start Year
2010
Number of shared co-authors
1
Asha A Nair
Mayo Clinic
Career Start Year
2010
Number of shared co-authors
0
Ganiraju C Manyam
the University of Texas MD Anderson Cancer Center
Career Start Year
2009
Number of shared co-authors
1
Richard Mitter
The Francis Crick Institute
Career Start Year
2008
Number of shared co-authors
0
Johannes Haybaeck
Institute of Pathology, Medical University of Innsbruck
Career Start Year
2007
Number of shared co-authors
0
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year
2006
Number of shared co-authors
0
Henry Yang
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year
2005
Number of shared co-authors
5
Liuqing Yang
University of Tennessee Health Science Center
Career Start Year
2004
Number of shared co-authors
0
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year
2004
Number of shared co-authors
0
Francesca Rizzo
University of Salerno and Genome Research Center for Health
Career Start Year
2004
Number of shared co-authors
2
Andrew V Kossenkov
The Wistar Institute
Career Start Year
2003
Number of shared co-authors
1
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year
2003
Number of shared co-authors
0
Amy G Robertson
Present address: Dxige Research Inc.
Career Start Year
2003
Number of shared co-authors
4
Bin Yan
The University of Hong Kong
Career Start Year
2003
Number of shared co-authors
0
Osvaldo Gra??a
Spanish National Cancer Research Centre-CNIO
Career Start Year
2002
Number of shared co-authors
1
Syed Haider
Institute of Cancer Research
Career Start Year
2002
Number of shared co-authors
8
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year
2001
Number of shared co-authors
0
Loris De Cecco
Fondazione IRCCS Istituto Nazionale dei Tumori
Career Start Year
2000
Number of shared co-authors
4
Victor Segura
Center for Applied Medical Research (CIMA)
Career Start Year
2000
Number of shared co-authors
1
Celine Lefebvre
The Scripps Research Institute
Career Start Year
1999
Number of shared co-authors
1
Sven Diederichs
Medical Center - University of Freiburg, University of Freiburg
Career Start Year
1999
Number of shared co-authors
2
Dongquan Chen
University of Alabama at Birmingham
Career Start Year
1997
Number of shared co-authors
0
Lianbo Yu
The Ohio State University
Career Start Year
1997
Number of shared co-authors
1
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year
1997
Number of shared co-authors
8
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year
1996
Number of shared co-authors
0
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year
1995
Number of shared co-authors
2
Anamaria A Camargo
Hospital Sirio-Libanes
Career Start Year
1994
Number of shared co-authors
2
Holger S??ltmann
German Cancer Research Center (DKFZ)
Career Start Year
1993
Number of shared co-authors
0
Wenbin Wei
Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield
Career Start Year
1991
Number of shared co-authors
2
row(s) 1 - 30 of 30
Collaborators
Silvano Piazza
International Centre for Genetic Engineering and Biotechnology
Co-authored papers
10
Claudio Schneider
Laboratorio Nazionale-Consorzio Interuniversitario per le Biotecnologie
Co-authored papers
8
Roberto Verardo
LNCIB - Consorzio Interuniversitario per le Biotecnologie c/o BIC Incubatori FVG
Co-authored papers
5
James F Reid
Co-authored papers
4
Luigi Marchionni
Weill-Cornell School of Medicine
Co-authored papers
4
Colin A Semple
Institute of Genetics and Cancer, University of Edinburgh
Co-authored papers
3
Shiro Fukuda
Graduate School of Medicine, Osaka University
Co-authored papers
3
Yoshihide Hayashizaki
Center for Integrative Medical Sciences
Co-authored papers
3
Takahiro Arakawa
Tokyo University of Technology
Co-authored papers
3
Jun Kawai
RIKEN Center for Integrative Medical Sciences
Co-authored papers
3
Julian Gough
Medical Research Council Laboratory of Molecular Biology
Co-authored papers
3
Masayoshi Itoh
RIKEN Center for Integrative Medical Sciences
Co-authored papers
3
Dejan Lazarevic
Co-authored papers
3
Timothy Ravasi
Okinawa Institute of Science and Technology Graduate University
Co-authored papers
3
Yari Ciani
University of Trento
Co-authored papers
3
Boris Lenhard
MRC London Institute of Medical Sciences
Co-authored papers
3
Christine A Wells
The University of Melbourne
Co-authored papers
3
Harukazu Suzuki
RIKEN Center for Integrative Medical Sciences
Co-authored papers
3
Graziano Pesole
Co-authored papers
3
Albin Sandelin
University of Copenhagen
Co-authored papers
3
David A Hume
Mater Research Institute-UQ, Translational Research Institute
Co-authored papers
3
Piero Carninci
RIKEN Center for Integrative Medical Sciences
Co-authored papers
3
Takeya Kasukawa
RIKEN Center for Integrative Medical Sciences
Co-authored papers
3
Yasushi Okazaki
Intractable Disease Research Center, Graduate School of Medicine, Juntendo University
Co-authored papers
3
Hideya Kawaji
RIKEN Center for Integrative Medical Sciences
Co-authored papers
3
Alistair R R Forrest
RIKEN Center for Integrative Medical Sciences
Co-authored papers
3
Stefano Gustincich
Istituto Italiano di Tecnologia
Co-authored papers
3
Martin S Taylor
Institute of Genetics and Cancer, University of Edinburgh
Co-authored papers
3
Noriko Ninomiya
Japan Tobacco Inc.
Co-authored papers
2
Winston Hide
Harvard Medical School
Co-authored papers
2
1 - 30